Global Diabetes Devices Market- Industry Analysis, Share, Size, Growth, Trends, Opportunity and Forecast 2022-2030

1 INTRODUCTION
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 DIABETES DEVICES TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2016-2020
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 BLOOD GLUCOSE MONITORING DEVICES
5.5.1 TESTING STRIPS
5.5.2 SELF-MONITORING BLOOD GLUCOSE METERS
5.5.3 LANCETS
5.5.4 CONTINUOUS GLUCOSE MONITORS
5.6 INSULIN DELIVERY DEVICES
5.6.1 INSULIN SYRINGES
5.6.2 INSULIN PENS
5.6.3 INSULIN PUMPS
5.6.4 INSULIN JET INJECTORS
5.7 DIABETES MANAGEMENT MOBILE APPLICATIONS
6 DIABETES DEVICES DISTRIBUTION CHANNELS ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET DISTRIBUTION CHANNELS ANALYSIS, 2016-2020
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 HOSPITAL PHARMACIES
6.6 RETAIL PHARMACIES
6.7 ONLINE PHARMACIES
6.8 DIABETES CLINICS
6.9 OTHERS
7 DIABETES DEVICES MARKET APPLICATION ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 HOSPITAL
7.6 HOMECARE
7.7 DIAGNOSTIC CENTERS
8 GLOBAL DIABETES DEVICES REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.2.3 Y-O-Y GROWTH TREND ANALYSIS
8.2.3.1 U.S.
8.2.3.2 Canada
8.2.3.3 Mexico
8.3 ASIA-PACIFIC
8.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.3.2 Y-O-Y GROWTH TREND ANALYSIS
8.3.2.1 China
8.3.2.2 Japan
8.3.2.3 Korea
8.3.2.4 India
8.3.2.5 Southeast Asia
8.4 MIDDLE EAST AND AFRICA
8.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.4.3 Y-O-Y GROWTH TREND ANALYSIS
8.4.3.1 Saudi Arabia
8.4.3.2 UAE
8.4.3.3 Egypt
8.4.3.4 Nigeria
8.4.3.5 South Africa
8.5 EUROPE
8.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.5.3 Y-O-Y GROWTH TREND ANALYSIS
8.5.3.1 Germany
8.5.3.2 France
8.5.3.3 UK
8.5.3.4 Russia
8.5.3.5 Italy
8.6 LATIN AMERICA
8.6.1 LATIN AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.6.3 Y-O-Y GROWTH TREND ANALYSIS
8.6.3.1 Brazil
8.6.3.2 Argentina
8.6.3.3 Columbia
9 MARKET PLAYERS
9.1 MEDTRONIC
9.1.1 BUSINESS OVERVIEW:
9.1.2 PRODUCT PORTFOLIO
9.1.3 RECENT DEVELOPMENTS
9.1.4 SWOT ANALYSIS:
9.2 ABBOTT
9.3 ASCENSIA DIABETES CARE HOLDINGS AG (FORMERLY DIABETES CASE BUSINESS OF BAYER AG)
9.4 DEXCOM, INC.
9.5 F. HOFFMANN-LA ROCHE LTD.
9.6 SANOFI
9.7 NOVO NORDISK A/S
9.8 INSULET CORPORATION
9.9 YPSOMED
9.10 VALERITAS, INC
9.11 ACON LABORATORIES, INC.
9.12 BECTON, DICKINSON AND COMPANY
9.13 JOHNSON & JOHNSON
9.14 TERUMO CORPORATION
9.15 ARKRAY, INC.
9.16 ECHO THERAPEUTICS, INC.
9.17 GLYSENS INCORPORATED
9.18 INSULET CORPORATION
9.19 SANOFI
9.20 YPSOMED AG
10 ABOUT US

FIGURE 1 GLOBAL DIABETES DEVICES MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL DIABETES DEVICES CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL DIABETES DEVICES CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 DIABETES DEVICES TYPE ANALYSIS
FIGURE 11 GLOBAL DIABETES DEVICES CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 DIABETES DEVICES DISTRIBUTION CHANNELS ANALYSIS
FIGURE 13 GLOBAL DIABETES DEVICES CURRENT AND FUTURE MARKET DISTRIBUTION CHANNELS ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 DIABETES DEVICES APPLICATION ANALYSIS
FIGURE 15 GLOBAL DIABETES DEVICES CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 GLOBAL DIABETES DEVICES CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 17 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 MARKET SHARE BY COUNTRY
FIGURE 19 NORTH AMERICA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 NORTH AMERICA DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 21 NORTH AMERICA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 U.S. DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 23 U.S. DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 CANADA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 25 CANADA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 MEXICO DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 MEXICO DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 MARKET SHARE BY COUNTRY
FIGURE 29 APAC DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 APAC DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 APAC DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 32 CHINA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 CHINA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 JAPAN DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 35 JAPAN DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 KOREA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 KOREA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 38 INDIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 INDIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 SOUTHEAST ASIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 SOUTHEAST ASIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 MARKET SHARE BY COUNTRY
FIGURE 43 MIDDLE EAST AND AFRICA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 MIDDLE EAST AND AFRICA DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 MIDDLE EAST AND AFRICA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 SAUDI ARABIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 47 SAUDI ARABIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 UAE DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 UAE DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 EGYPT DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 51 EGYPT DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 NIGERIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 NIGERIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 SOUTH AFRICA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 55 SOUTH AFRICA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 MARKET SHARE BY COUNTRY
FIGURE 57 EUROPE DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 EUROPE DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 EUROPE DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 GERMANY DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 GERMANY DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 62 FRANCE DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 FRANCE DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 UK DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 UK DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 RUSSIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 67 RUSSIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 ITALY DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 ITALY DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 MARKET SHARE BY COUNTRY
FIGURE 71 LATIN AMERICA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 LATIN AMERICA DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 LATIN AMERICA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 BRAZIL DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 BRAZIL DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 ARGENTINA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 77 ARGENTINA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 COLUMBIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 COLUMBIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 FINANCIAL OVERVIEW: